{"id":205958,"name":"ATEA PHARMACEUTICALS","slug":"atea-pharmaceuticals","state":"MA","country":"United States of America","description":"Drug development and COVID 19 issues involving FDA, DOD, HHS, and OWS","totalSpending":160000,"filings":18,"yearlySpending":[{"year":2020,"income":60000},{"year":2021,"income":70000},{"year":2022,"income":30000},{"year":2023,"income":0},{"year":2024,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["BURT ROSEN STRATEGIES"],"lobbyists":["BURT ROSEN"],"govEntities":["Defense, Dept of (DOD)","Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)","Veterans Affairs, Dept of (VA)","SENATE","HOUSE OF REPRESENTATIVES"],"sampleDescriptions":["Covid-19 Drug development involving DOD, HHS, FDA, and OWS","Drug Development for COVID","Drug Development for COVID","Drug Development for COVID","Covid treatment issues"]}